programmatic and clinical management of DR-TB in order to achieve sustainable development goals

A 9-days comprehensive post-graduate course for clinicians is designed combining the latest up-to-date policy framework, guidance and evidence in clinical and programmatic management of DR-TB with intensive practical work of the participants– interactive case studies, group discussions and presentations. 

Most of the courses take place in WHO CC Latvia facilities, located at the TB and Lung Diseases Centre of Riga East University hospital with field visits to the DR-TB department, National TB Reference Laboratory, and TB Outpatient department, including collaboration with other social/health/NGO sectors in providing care for the patients. WHO CC Latvia regularly involves regional experts from the field in the provision of the course. WHO CC Latvia ensures full logistic support to participants - including accommodation, local transfers, meals and visa invitation.

Lorem ipsum headerum

Diam quis enim lobortis scelerisque fermentum dui faucibus in ornare quam viverra.
Mauris commodo quis imperdiet massa tincidunt nunc pulvinar sapien.

A 7-days comprehensive post-graduate course for clinicians is designed to combine the latest up-to-date policy framework, guidance and evidence in clinical and programmatic management of DR-TB with intensive practical work of the participants– interactive case studies, group discussions and presentations.

Course content

  • Global epidemiology of TB, DR-TB, TB/HIV, and WHO strategy and targets for TB prevention, care, and control.
  • Updates on the diagnosis of TB and DR-TB. 
  • Clinical aspects of case detection of DR-TB.
  • Use of shorter DR-TB regimens in European regions. New guidelines for the treatment of RR-TB. Treatment regimen design for DR-TB.
  • TB diagnosis and treatment for HIV co-infected patients. Possible drug-drug interactions between antiretrovirals and the new TB drugs.

  • Diagnosis and treatment of latent TB infection
  • Management of TB in children. Management of DR-TB in special situations.  Adjuvant therapies in DR-TB management.
  • Monitoring of DR-TB treatment effectiveness.
  • Pharmacovigilance. Active drug safety monitoring and management (aDSM).
  • Fundamentals of infection control; FAST: a TB infection control strategy.
  • Contact finding and investigation.

  • Organization of TB outpatient treatment and care.
  • Developing models of care for DR-TB patients; people-centered TB care.
  • Health communication for health care workers working with TB.
  • Management of failures and chronic patients.
  • Intersectoral collaboration on ending TB, HIV, and Hepatitis C in countries.
  • Site visits to DR-TB department, National TB Reference Laboratory and TB Outpatient department.

Duration and language

9 business days (from Monday to Wednesday, including Saturday). Available in Russian and English

Target audience  

clinicians, staff of national TB programs, persons responsible for diagnostics and treatment of DR-TB, from countries with high levels of DR-TB

Training fee

1700 EUR, including training materials, site visit, local transport, catering during working hours/on working days, visa support (excluding hotel accommodation, international flight, visa costs and daily allowance)